Adimmune Corp
TWSE:4142
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adimmune Corp
TWSE:4142
|
TW |
|
B
|
Boston Scientific Corp
DUS:BSX
|
US |
|
B
|
Bee Vectoring Technologies International Inc
CNSX:BEE
|
CA |
|
Bluglass Ltd
ASX:BLG
|
AU |
|
T
|
Truwin Co Ltd
KOSDAQ:105550
|
KR |
|
Nankai Plywood Co Ltd
TSE:7887
|
JP |
|
Invent Ventures Inc
OTC:IDEA
|
US |
|
W
|
Worldlink Group PLC
LSE:WGP
|
UK |
|
M
|
Mooreast Holdings Ltd
SGX:1V3
|
SG |
|
Acacia Research Corp
NASDAQ:ACTG
|
US |
|
S
|
Sino Land Co Ltd
XMUN:SNO
|
HK |
|
Adastria Co Ltd
TSE:2685
|
JP |
|
M
|
Multicell Technologies Inc
OTC:MCET
|
US |
|
Macerich Co
NYSE:MAC
|
US |
|
Repay Holdings Corp
NASDAQ:RPAY
|
US |
|
National Research Corp
NASDAQ:NRC
|
US |
|
Lindbergh SpA
F:D8M
|
IT |
|
H
|
HLB Inc
KOSDAQ:028300
|
KR |
Dividends
Dividend Yield
Adimmune Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Adimmune Corp
Adimmune Corp have decreased by 0%.
Payout Ratio
Adimmune Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Adimmune Corp is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Adimmune Corp
| Average Annual Return | -15.61% |
| Standard Deviation of Annual Returns | 14.63% |
| Max Drawdown | -69% |
| Market Capitalization | 7.5B TWD |
| Shares Outstanding | 429 510 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Adimmune Corp's latest stock split occurred on Apr 18, 2019
The company executed a 1323-for-1256 stock split, meaning that for every 1256 shares held, investors received 1323 new shares.
Before the split, Adimmune Corp traded at 23.1209 per share. Afterward, the share price was about 20.8084.
The adjusted shares began trading on Apr 18, 2019. This was the only stock split in Adimmune Corp's history.